201 related articles for article (PubMed ID: 27186987)
1. Inferring RBP-Mediated Regulation in Lung Squamous Cell Carcinoma.
Lafzi A; Kazan H
PLoS One; 2016; 11(5):e0155354. PubMed ID: 27186987
[TBL] [Abstract][Full Text] [Related]
2. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
Wu X; Ruan L; Yang Y; Mei Q
Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
[TBL] [Abstract][Full Text] [Related]
3. Role of downregulated ADARB1 in lung squamous cell carcinoma.
Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
[TBL] [Abstract][Full Text] [Related]
5. Integration of multi-omics data to mine cancer-related gene modules.
Li P; Guo M; Sun B
J Bioinform Comput Biol; 2019 Dec; 17(6):1950038. PubMed ID: 32019413
[TBL] [Abstract][Full Text] [Related]
6. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
[TBL] [Abstract][Full Text] [Related]
7. Transcription Factors Contribute to Differential Expression in Cellular Pathways in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Liu S; Wang X; Qin W; Genchev GZ; Lu H
Interdiscip Sci; 2018 Dec; 10(4):836-847. PubMed ID: 30039492
[TBL] [Abstract][Full Text] [Related]
8. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
9. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Li Q; Hou J; Hu Z; Gu B; Shi Y
Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
[TBL] [Abstract][Full Text] [Related]
10. Coordinating expression of RNA binding proteins with their mRNA targets.
Jiang H; Xu L; Wang Z; Keene J; Gu Z
Sci Rep; 2014 Nov; 4():7175. PubMed ID: 25417751
[TBL] [Abstract][Full Text] [Related]
11. Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer development.
Chen Y; Widschwendter M; Teschendorff AE
Genome Biol; 2017 Dec; 18(1):236. PubMed ID: 29262847
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive expression landscape of RNA-binding proteins (RBPs) across 16 human cancer types.
Zhang B; Babu KR; Lim CY; Kwok ZH; Li J; Zhou S; Yang H; Tay Y
RNA Biol; 2020 Feb; 17(2):211-226. PubMed ID: 31607220
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
16. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gene expression profiles of lung cancer subtypes with machine learning algorithms.
Yuan F; Lu L; Zou Q
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165822. PubMed ID: 32360590
[TBL] [Abstract][Full Text] [Related]
19. Human protein-RNA interaction network is highly stable across mammals.
Ramakrishnan A; Janga SC
BMC Genomics; 2019 Dec; 20(Suppl 12):1004. PubMed ID: 31888461
[TBL] [Abstract][Full Text] [Related]
20. Modeling the combined effect of RNA-binding proteins and microRNAs in post-transcriptional regulation.
HafezQorani S; Lafzi A; de Bruin RG; van Zonneveld AJ; van der Veer EP; Son YA; Kazan H
Nucleic Acids Res; 2016 May; 44(9):e83. PubMed ID: 26837572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
